Evidence map›Paper›PMID 31696212›Full record

Observational studyArchives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists2021

Metabolic Risk Factors as Differential Predictors of Profiles of Neurocognitive Impairment Among Older HIV+ and HIV- Adults: An Observational Study.

Elizabeth C Pasipanodya, Jessica L Montoya, Laura M Campbell, Mariam A Hussain, Rowan Saloner, Emily M Paolillo, Dilip V Jeste, Scott L Letendre, J Allen McCutchan, Robert K Heaton and 1 more

Abstract readObservational Study
In one paragraph

Observational study in Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Elizabeth C PasipanodyaSanta Clara Valley Medical Center, Rehabilitation Research Center, San Jose, CA, USA.
Jessica L MontoyaUniversity of California, San Diego, HIV Neurobehavioral Research Program, San Diego, CA, USA.
Laura M CampbellSan Diego State University/University of California,San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA.
Mariam A HussainSan Diego State University/University of California,San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA.
Rowan SalonerSan Diego State University/University of California,San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA.
Emily M PaolilloSan Diego State University/University of California,San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA.
Dilip V JesteUniversity of California, San Diego, Sam and Rose Stein Institute on Aging, La Jolla, CA, USA.
Scott L LetendreUniversity of California, San Diego, HIV Neurobehavioral Research Program, San Diego, CA, USA.
J Allen McCutchanUniversity of California, San Diego, HIV Neurobehavioral Research Program, San Diego, CA, USA.
Robert K HeatonUniversity of California, San Diego, HIV Neurobehavioral Research Program, San Diego, CA, USA.
David J MooreUniversity of California, San Diego, HIV Neurobehavioral Research Program, San Diego, CA, USA.

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jennifer E Iudicello · 2001 to 2026
$50.4M
Training in Research on Addictions in Interdisciplinary NeuroAIDS (TRAIN)T32DA031098 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jennifer E Iudicello, DAVID J MOORE · 2011 to 2026
$4.6M
Multi-Dimensional Successful Aging Among HIV-Infected AdultsR01MH099987 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JESTE, DILIP V., MOORE, DAVID J · 2013 to 2019
$3.8M
SuperAging in HIV-infected Adults: Biopsychosocial Predictors of Neurocognitive Aging TrajectoriesF31AG064989 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SALONER, ROWAN · 2019 to 2021
$118k
NIA NIH HHS F31 AG064989NIDA NIH HHS T32 DA031098NIMH NIH HHS P30 MH062512NIMH NIH HHS R01 MH099987
6 · The paper itself

Abstract

objectiveNeurocognitive performance among older persons, including those living with HIV (people living with HIV [PLWH]), exhibits significant heterogeneity, suggesting subpopulations with differing profiles of neurocognitive impairment (NCI). Metabolic factors are associated with NCI, but their relationships to cluster-derived NCI profiles are unknown.

methodParticipants (144 PLWH and 102 HIV uninfected) aged 50+ years completed a neuropsychological battery assessing seven cognitive domains. Latent class analysis (LCA) identified NCI profiles separately by HIV serostatus and in a combined sample. Obtained classes were examined against the Montreal Cognitive Assessment (MoCA) and diagnoses of HIV-associated neurocognitive disorders (HAND). Multinomial regression identified metabolic predictors of classification.

resultsLCA identified three latent classes in each participant sample: Class1Multidomain NCI (high probability of impairment across multiple domains), Class 2Learning & Recall NCI (high probability of impairment in learning and recall), and Class 3NC Unimpaired (low probability of NCI across all domains). Severity of NCI implied by classes corresponded with MoCA scores and HAND diagnoses. In analyses on the combined sample, compared to HIV-uninfected individuals, PLWH were more likely to be in Class1Multidomain NCI. Among PLWH, those with dyslipidemia and hypertension had greater odds of classification in Class 1Multidomain NCI while those with central obesity had higher odds of classification in Class 2Learning & Recall NCI; metabolic syndrome approached significance as a differential predictor. Regardless of HIV status, individuals with diabetes were more likely to be in Class 1Multidomain NCI.

conclusionsMetabolic risk factors confer heightened risk of NCI in HIV infection. Interventions to reduce metabolic risk may improve neurocognitive outcomes among PLWH.

Indexed as

HIV InfectionsAdultAgedAged, 80 and overHumansMental Status and Dementia TestsMiddle AgedNeurocognitive DisordersNeuropsychological TestsRisk FactorsHIVlatent class analysismetabolic syndromeneurocognitive impairment

Identifiers

PMID31696212
PMCPMC7881975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.